메뉴 건너뛰기




Volumn 56, Issue 11, 2015, Pages 3038-3044

A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma

Author keywords

Anemia; extranodal NK T cell lymphoma; hemoglobin; international prognostic index; prognosis

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

EID: 84947730596     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2015.1026817     Document Type: Article
Times cited : (13)

References (39)
  • 1
    • 5344263788 scopus 로고    scopus 로고
    • The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
    • Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40: 2293-2306.
    • (2004) Eur J Cancer , vol.40 , pp. 2293-2306
    • Ludwig, H.1    Van Belle, S.2    Barrett-Lee, P.3
  • 2
    • 0031741680 scopus 로고    scopus 로고
    • Frequency and significance of anemia in non-Hodgkin's lymphoma patients
    • Moullet I, Salles G, Ketterer N, et al. Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol 1998; 9: 1109-1115.
    • (1998) Ann Oncol , vol.9 , pp. 1109-1115
    • Moullet, I.1    Salles, G.2    Ketterer, N.3
  • 3
    • 0025315364 scopus 로고
    • Decreased erythropoietin response in patients with the anemia of cancer
    • Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-1692.
    • (1990) N Engl J Med , vol.322 , pp. 1689-1692
    • Miller, C.B.1    Jones, R.J.2    Piantadosi, S.3
  • 4
    • 0026629718 scopus 로고
    • Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
    • Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994.
    • (1992) Blood , vol.79 , pp. 1987-1994
    • Faquin, W.C.1    Schneider, T.J.2    Goldberg, M.A.3
  • 5
    • 0026569973 scopus 로고
    • Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
    • Jelkmann W, Pagel H, Wolff M, et al. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992; 50: 301-308.
    • (1992) Life Sci , vol.50 , pp. 301-308
    • Jelkmann, W.1    Pagel, H.2    Wolff, M.3
  • 6
    • 84903781218 scopus 로고    scopus 로고
    • Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
    • Hamai Y, Hihara J, Taomoto J, et al. Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma. World J Surg 2014; 38: 2046-2051.
    • (2014) World J Surg , vol.38 , pp. 2046-2051
    • Hamai, Y.1    Hihara, J.2    Taomoto, J.3
  • 7
    • 0034046859 scopus 로고    scopus 로고
    • Impact of anemia in patients with head and neck cancer
    • Kumar P. Impact of anemia in patients with head and neck cancer. Oncologist 2000; 5: 13-18.
    • (2000) Oncologist , vol.5 , pp. 13-18
    • Kumar, P.1
  • 8
    • 35448944907 scopus 로고    scopus 로고
    • The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer
    • Rutkowski T, Suwinski R, Idasiak A. The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer. Int J Radiat Oncol Biol Phys 2007; 69: 1018-1023.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , pp. 1018-1023
    • Rutkowski, T.1    Suwinski, R.2    Idasiak, A.3
  • 9
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-hodgkin's lymphoma the international non-hodgkin's lymphoma prognostic factors project
    • A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 10
    • 4444326818 scopus 로고    scopus 로고
    • Follicular lymphoma international prognostic index
    • Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
    • (2004) Blood , vol.104 , pp. 1258-1265
    • Solal-Celigny, P.1    Roy, P.2    Colombat, P.3
  • 11
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
    • Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842-854.
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.1    Salmon, S.E.2
  • 12
    • 0017751562 scopus 로고
    • A clinical staging system for chronic lymphocytic leukemia: Prognostic significance
    • Binet JL, Lepoprier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977; 40: 855-864.
    • (1977) Cancer , vol.40 , pp. 855-864
    • Binet, J.L.1    Lepoprier, M.2    Dighiero, G.3
  • 13
    • 65349135347 scopus 로고    scopus 로고
    • Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma
    • Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009; 15: 2905-2912.
    • (2009) Clin Cancer Res , vol.15 , pp. 2905-2912
    • Li, Y.X.1    Liu, Q.F.2    Fang, H.3
  • 14
    • 84872183512 scopus 로고    scopus 로고
    • Cyclophosphamide doxorubicin vincristine and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma nasal type: 13-year follow-up in 135 patients
    • Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Int J Hematol 2012; 96: 617-623.
    • (2012) Int J Hematol , vol.96 , pp. 617-623
    • Wang, L.1    Xia, Z.J.2    Huang, H.Q.3    Lu, Y.4    Zhang, Y.J.5
  • 15
    • 84893010631 scopus 로고    scopus 로고
    • Combination of gemcitabine L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: A retrospective study in a cohort of 227 patients with long-term follow-up
    • Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y. Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Med Oncol 2014; 31: 860.
    • (2014) Med Oncol , vol.31 , pp. 860
    • Wang, L.1    Wang, W.D.2    Xia, Z.J.3    Zhang, Y.J.4    Xiang, J.5    Lu, Y.6
  • 16
    • 0031962152 scopus 로고    scopus 로고
    • Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
    • Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70-77.
    • (1998) J Clin Oncol , vol.16 , pp. 70-77
    • Cheung, M.M.1    Chan, J.K.2    Lau, W.H.3
  • 17
    • 0036720257 scopus 로고    scopus 로고
    • Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
    • Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182-190.
    • (2002) Int J Radiat Oncol Biol Phys , vol.54 , pp. 182-190
    • Cheung, M.M.1    Chan, J.K.2    Lau, W.H.3    Ngan, R.K.4    Foo, W.W.5
  • 18
    • 33644843494 scopus 로고    scopus 로고
    • Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
    • Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612-618.
    • (2006) J Clin Oncol , vol.24 , pp. 612-618
    • Lee, J.1    Suh, C.2    Park, Y.H.3
  • 19
    • 84872087371 scopus 로고    scopus 로고
    • First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
    • Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 2013; 119: 348-355.
    • (2013) Cancer , vol.119 , pp. 348-355
    • Wang, L.1    Zh, W.2    Chen, X.Q.3
  • 20
    • 79957516735 scopus 로고    scopus 로고
    • Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: A single-institution experience
    • Huang H, Lin Z, Lin X, Cai Q, Xia Z, Jiang W. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leuk Lymphoma 2011; 52: 1041-1048.
    • (2011) Leuk Lymphoma , vol.52 , pp. 1041-1048
    • Huang, H.1    Lin, Z.2    Lin, X.3    Cai, Q.4    Xia, Z.5    Jiang, W.6
  • 21
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
    • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
    • (1999) J Clin Oncol , vol.17 , pp. 1244
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 22
    • 0020676280 scopus 로고
    • Mechanisms of abnormal erythropoiesis in malignancy
    • Dainiak N, Kulkarni V, Howard D, et al. Mechanisms of abnormal erythropoiesis in malignancy. Cancer 1983; 51: 1101-1106.
    • (1983) Cancer , vol.51 , pp. 1101-1106
    • Dainiak, N.1    Kulkarni, V.2    Howard, D.3
  • 23
    • 84899509396 scopus 로고    scopus 로고
    • Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma
    • Zhang J, Wang WD, Geng QR, et al. Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma. PLoS One 2014; 9: e94637.
    • (2014) PLoS One , vol.9 , pp. e94637
    • Zhang, J.1    Wang, W.D.2    Geng, Q.R.3
  • 24
    • 84938055809 scopus 로고    scopus 로고
    • Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma
    • Wang H, Zhu JY, Liu CC, et al. Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma. Med Oncol 2015; 32: 370.
    • (2015) Med Oncol , vol.32 , pp. 370
    • Wang, H.1    Zhu, J.Y.2    Liu, C.C.3
  • 25
    • 84883704858 scopus 로고    scopus 로고
    • Clinical significance of serum soluble interleukin-2 receptor-alpha in extranodal natural killer/T-cell lymphoma (ENKTL): A predictive biomarker for treatment efficacy and valuable prognostic factor
    • Wang L, Liao DZ, Zhang J, et al. Clinical significance of serum soluble interleukin-2 receptor-alpha in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor. Med Oncol 2013; 30: 723.
    • (2013) Med Oncol , vol.30 , pp. 723
    • Wang, L.1    Liao, D.Z.2    Zhang, J.3
  • 26
    • 0033824339 scopus 로고    scopus 로고
    • Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues
    • Henke M, Bechtold C, Momm F, et al. Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues. Int J Radiat Oncol Biol Phys 2000; 48: 339-345.
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 339-345
    • Henke, M.1    Bechtold, C.2    Momm, F.3
  • 27
    • 0032708195 scopus 로고    scopus 로고
    • Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
    • Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999; 53: 113-117.
    • (1999) Radiother Oncol , vol.53 , pp. 113-117
    • Brizel, D.M.1    Dodge, R.K.2    Clough, R.W.3
  • 28
    • 0030854534 scopus 로고    scopus 로고
    • Evaluation of the concept of hypoxic fraction as a descriptor of tumor oxygenation status
    • Evans SM, Jenkins WT, Shapiro M, et al. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status. Adv Exp Med Biol 1997; 411: 215-225.
    • (1997) Adv Exp Med Biol , vol.411 , pp. 215-225
    • Evans, S.M.1    Jenkins, W.T.2    Shapiro, M.3
  • 29
    • 84858707231 scopus 로고    scopus 로고
    • Radiotherapy alone with curative intent in patients with stage i extranodal nasal-type NK/T-cell lymphoma
    • Li YX, Wang H, Jin J, et al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 2012; 82: 1809-1815.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 1809-1815
    • Li, Y.X.1    Wang, H.2    Jin, J.3
  • 30
    • 0342905409 scopus 로고    scopus 로고
    • Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment
    • Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54-63.
    • (2000) J Clin Oncol , vol.18 , pp. 54-63
    • Kim, G.E.1    Cho, J.H.2    Yang, W.I.3
  • 31
    • 53549130011 scopus 로고    scopus 로고
    • Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
    • Wang B, Li XQ, Ma X, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol 2008; 83: 795-799.
    • (2008) Am J Hematol , vol.83 , pp. 795-799
    • Wang, B.1    Li, X.Q.2    Ma, X.3
  • 32
    • 81755172136 scopus 로고    scopus 로고
    • Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group study
    • Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011; 29: 4410-4416.
    • (2011) J Clin Oncol , vol.29 , pp. 4410-4416
    • Yamaguchi, M.1    Kwong, Y.L.2    Kim, W.S.3
  • 33
    • 79951483189 scopus 로고    scopus 로고
    • Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
    • Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 2011; 117: 1834-1839.
    • (2011) Blood , vol.117 , pp. 1834-1839
    • Jaccard, A.1    Gachard, N.2    Marin, B.3
  • 34
    • 65449159015 scopus 로고    scopus 로고
    • Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project
    • Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009; 113: 3931-3937.
    • (2009) Blood , vol.113 , pp. 3931-3937
    • Au, W.Y.1    Weisenburger, D.D.2    Intragumtornchai, T.3
  • 35
    • 84919917940 scopus 로고    scopus 로고
    • Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type
    • Jiang L, Li P, Wang H, et al. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type. Med Oncol 2014; 31: 218.
    • (2014) Med Oncol , vol.31 , pp. 218
    • Jiang, L.1    Li, P.2    Wang, H.3
  • 36
    • 84878410620 scopus 로고    scopus 로고
    • Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type
    • Li YJ, Li ZM, Xia Y, et al. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type. PLoS One 2013; 8: e64158.
    • (2013) PLoS One , vol.8 , pp. e64158
    • Li, Y.J.1    Li, Z.M.2    Xia, Y.3
  • 37
    • 84919904805 scopus 로고    scopus 로고
    • A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type
    • Wang KF, Chang BY, Chen XQ, et al. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type. Med Oncol 2014; 31: 318.
    • (2014) Med Oncol , vol.31 , pp. 318
    • Wang, K.F.1    Chang, B.Y.2    Chen, X.Q.3
  • 38
    • 84914098795 scopus 로고    scopus 로고
    • Targeting the PD-1/PD-L1 immune checkpoint signal-a new treatment strategy for cancer
    • Hamanishi J, Konishi I. [Targeting the PD-1/PD-L1 immune checkpoint signal-a new treatment strategy for cancer]. Gan To Kagaku Ryoho 2014; 41: 1071-1076.
    • (2014) Gan to Kagaku Ryoho , vol.41 , pp. 1071-1076
    • Hamanishi, J.1    Konishi, I.2
  • 39
    • 84924357098 scopus 로고    scopus 로고
    • CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
    • Li P, Jiang L, Zhang X, et al. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. BMC Cancer 2014; 14: 890.
    • (2014) BMC Cancer , vol.14 , pp. 890
    • Li, P.1    Jiang, L.2    Zhang, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.